No Read Through to Biogen (BIIB) from Teva (TEVA) Copaxone IPR Result - Jefferies
Go back to No Read Through to Biogen (BIIB) from Teva (TEVA) Copaxone IPR Result - Jefferies| BIOGEN IDEC Inc. (NASDAQ: BIIB) | Delayed: 199.56 -2.43 (1.2%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $201.99 | 52 Week High | $333.65 | |||
| Open | $201.21 | 52 Week Low | $223.02 | |||
| Day High | $205.36 | P/E | 25.55 | |||
| Day Low | $198.11 | EPS | $7.81 | |||
| Volume | 484,562 | |||||
| TEVA PHARMACEUTICAL INDUSTRIES (NYSE: TEVA) | Delayed: 13.02 +0.01 (0.08%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $13.01 | 52 Week High | $66.55 | |||
| Open | $12.81 | 52 Week Low | $37.82 | |||
| Day High | $13.09 | P/E | N/A | |||
| Day Low | $12.80 | EPS | $0.00 | |||
| Volume | 2,387,457 | |||||
